In 2024, the U.S. Drug Enforcement Administration (DEA) indicated that they plan to reclassify cannabis being a Agenda III drug. This rescheduling will realize that cannabis has legitimate clinical applications and should help open up the door to research on other potential therapy uses.Dr. Ratner implies commencing with a lower dose of ten to twen